This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/517579-pfizer-covid-vaccine-brazilian-variant/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
Pfizer Covid vaccine successfully neutralizes Brazilian variant – lab study Pfizer Covid vaccine successfully neutralizes Brazilian variant – lab study
(6 months later)
A study has found that Pfizer’s Covid vaccine successfully neutralizes the Brazilian strain of the virus, a mutation that has sparked concerns due to its contagious nature and ability to evade immunity from previous infection.A study has found that Pfizer’s Covid vaccine successfully neutralizes the Brazilian strain of the virus, a mutation that has sparked concerns due to its contagious nature and ability to evade immunity from previous infection.
The study, conducted in a laboratory, was published on Monday by the New England Journal of Medicine. It saw scientists from the University of Texas Medical Branch successfully combat an engineered version of the virus.The study, conducted in a laboratory, was published on Monday by the New England Journal of Medicine. It saw scientists from the University of Texas Medical Branch successfully combat an engineered version of the virus.
The P1 variant was first detected in Japanese travelers who tested positive for Covid-19 after returning from Manaus, Brazil. Due to unique differences in its spike protein, it can spread rapidly among those who come into contact with it, like the Kent variant, with scientists describing the Brazilian strain as a “variant of concern.”The P1 variant was first detected in Japanese travelers who tested positive for Covid-19 after returning from Manaus, Brazil. Due to unique differences in its spike protein, it can spread rapidly among those who come into contact with it, like the Kent variant, with scientists describing the Brazilian strain as a “variant of concern.”
Previous laboratory studies have found the Pfizer vaccine to be effective in protecting recipients from other strains, including the South African variant, although there were some fears that mutations could have a minor reduction on the protective antibodies received from the dose.Previous laboratory studies have found the Pfizer vaccine to be effective in protecting recipients from other strains, including the South African variant, although there were some fears that mutations could have a minor reduction on the protective antibodies received from the dose.
Pfizer is currently exploring alterations that can be made to the virus or changes in the recommended number of doses, potentially adding a third booster shot, to help ensure maximum protection from new strains.Pfizer is currently exploring alterations that can be made to the virus or changes in the recommended number of doses, potentially adding a third booster shot, to help ensure maximum protection from new strains.
Since the Brazilian strain first emerged, it has spread to the UK, where six infected cases were identified, Japan were four travelers are thought to have brought it back to Tokyo, and a number of European countries that had arrivals from the Amazonas region.Since the Brazilian strain first emerged, it has spread to the UK, where six infected cases were identified, Japan were four travelers are thought to have brought it back to Tokyo, and a number of European countries that had arrivals from the Amazonas region.
The study is likely to boost interest in the Pfizer vaccine, with countries such as New Zealand and South Africa already favoring it over alternatives, like the AstraZeneca jab, which have shown lower protection against variants of the virus.The study is likely to boost interest in the Pfizer vaccine, with countries such as New Zealand and South Africa already favoring it over alternatives, like the AstraZeneca jab, which have shown lower protection against variants of the virus.
Like this story? Share it with a friend!Like this story? Share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.